N&O 100
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Nektar Therapeutics (NQ: NKTR)
9.790 USD  +0.190 (+1.98%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 9.680
Bid (Size) 9.790 (14600)
Ask (Size) 9.800 (25100)
Prev. Close 9.600
Today's Range 9.560 - 9.920
52wk Range 5.650 - 11.34
Shares Outstanding 115,522,958
Dividend Yield N/A
Top News
More News
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
May 16, 2013
from PR Newswire
Nektar Therapeutics Enters Oversold Territory (NKTR)
May 10, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video

More News
Read More
Nektar Therapeutics (NKTR) Misses Q1 EPS by 6c, Sales Rise
May 09, 2013
from StreetInsider.com News Articles
Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
May 09, 2013
from PR Newswire
Nektar to Announce Financial Results for the First Quarter of 2013 on Thursday, May 9, 2013, After Close of U.S.-Based Financial Markets
May 02, 2013
from PR Newswire
55.5% Return Seen to Date on SmarTrend Nektar Therapeutics Call (NKTR)
April 30, 2013
from Comtex SmarTrend® News Briefs
Uptrend Call Working As Nektar Therapeutics Stock Rises 53.6% (NKTR)
April 22, 2013
from Comtex SmarTrend® News Briefs
Critical Alerts For Intel, Delta, Southern Copper, Lam Research, and Nektar Therapeutics Released By InvestorsObserver
April 17, 2013
from PR Newswire
Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
April 16, 2013
from PR Newswire
Nektar Therapeutics Up 49.5% Since SmarTrend Uptrend Call (NKTR)
April 15, 2013
from Comtex SmarTrend® News Briefs
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here